The U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...

A behavior modification program that features positive and negative incentives reduced the use of ps...

Physicians fail to diagnose the majority of cases of catatonia in a general hospital setting, which ...

An expert panel of clinicians and researchers has published comprehensive guidelines for treatment o...

APA this week released the Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psy...

Citalopram may be of limited use for the treatment of agitation in patients with Alzheimer’s disease...

A combination of dextromethorphan (a cough suppressant) and quinidine (an antiarrhythmic medication)...